Literature DB >> 24283179

A comparison of the effect of levonorgestrel IUD with oral medroxyprogesterone acetate on abnormal uterine bleeding with simple endometrial hyperplasia and fertility preservation.

M Karimi-Zarchi1, R Dehghani-Firoozabadi, A Tabatabaie, Z Dehghani-Firoozabadi, S Teimoori, Z Chiti, A Miratashi-Yazdi, A Dehghani.   

Abstract

OBJECTIVE: Endometrial hyperplasia is clinically important, because it can lead to abnormal uterine bleeding (AUB) which itself can precede endometrial cancer. Endometrial carcinoma is the most common malignancy of the female genital tract, occurring in about 75%-85% younger, perimenopausal women as endometrial hyperplasia. The treatment is hysterectomy or hormone therapy with progesterone. The aim of this study was, therefore, to compare the effect of levonorgestrel intrauterine device (LNG-IUD) with medroxyprogesterone acetate (MPA) on simple endometrial hyperplasia for fertility preservation.
MATERIALS AND METHODS: Forty women in reproductive age (22-47 years) with AUB with endometrial biopsies confirming simple hyperplasia, were enrolled in this study and then randomly divided into two groups. All patients presented with designed special checklist which was filled with satisfaction. Complete history and physical examination especially blood pressure (BP), body mass index (BMI), breast examination, bimanual vaginal examination, and transvaginal sonography (to measure the thickness of endometrial and exclude the other pathologic lesions) were performed. In the first group, treatment was performed with MPA (20 mg/daily) for ten days and in other group with LNG-IUD was prescribed. After three months, transvaginal sonography and biopsy of endometrium were done. The status of AUB and side-effects of two methods,along with the rate of satisfactory were evaluated. RESULT: The findings showed the significant differences in the treatment of simple hyperplasia between two groups (LNG-IUD group vs. MPA group) (p < 0.047). Recovery of AUB in the group LNG was enhanced (p < 0.047). Endometrial thickness was reduced in both groups (p < 0.001), but further reduction in LNG group was seen. Also, LNG was tolerated more than MPA. Side-effects of MPA were more and reached significance (p < 0.003). The rate of satisfaction with LNG was higher than MPA and reached significance (p < 0.048).
CONCLUSION: The results of this study show that LNG-IUD is more effective than MPA in treatment of simple endometrial hyperplasia and can be helpful in young women who want to preserve their fertilities.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24283179

Source DB:  PubMed          Journal:  Clin Exp Obstet Gynecol        ISSN: 0390-6663            Impact factor:   0.146


  10 in total

1.  Levonorgestrel-releasing intrauterine system for endometrial hyperplasia.

Authors:  Theresa Mittermeier; Charlotte Farrant; Michelle R Wise
Journal:  Cochrane Database Syst Rev       Date:  2020-09-06

2.  Levonorgestrel-releasing intrauterine system (Mirena) in compare to medroxyprogesterone acetate as a therapy for endometrial hyperplasia.

Authors:  Fariba Behnamfar; Attaollah Ghahiri; Marzieh Tavakoli
Journal:  J Res Med Sci       Date:  2014-08       Impact factor: 1.852

3.  Evaluate the Effectiveness of Conservative Treatment for Menorrhagia in Women who were Admitted to the Shahid Sadoughi Hospital of Yazd-Iran in 2014-2015.

Authors:  M Karimi-Zarchi; M Zaid Abadinezhad; B Bonyadpour; S Kabyrpour-Ashkezar; A M Abhaji
Journal:  Int J Biomed Sci       Date:  2016-09

Review 4.  Comparison among fertility-sparing therapies for well differentiated early-stage endometrial carcinoma and complex atypical hyperplasia.

Authors:  Qing Zhang; Gonghua Qi; Margaux J Kanis; Ruifen Dong; Baoxia Cui; Xingsheng Yang; Beihua Kong
Journal:  Oncotarget       Date:  2017-05-03

5.  Abnormal uterine bleeding and associated factors among reproductive age women in Jimma town, Oromia Region, Southwest Ethiopia.

Authors:  Urge Gerema; Kumsa Kene; Deriba Abera; Tesfaye Adugna; Mebrat Nigussie; Diriba Dereje; Temesgen Mulugeta
Journal:  Womens Health (Lond)       Date:  2022 Jan-Dec

6.  A Meta-Analysis for Association of XRCC3 rs861539, MTHFR rs1801133, IL-6 rs1800795, IL-12B rs3212227, TNF-α rs1800629, and TLR9 rs352140 Polymorphisms with Susceptibility to Cervical Carcinoma.

Authors:  Seyedeh Fatemeh Parsaeian; Fatemeh Asadian; Mojgan Karimi-Zarchi; Sepideh Setayesh; Atiyeh Javaheri; Razieh Sadat Tabatabaie; Seyed Alireza Dastgheib; Hossein Golestanpour; Hossein Neamatzadeh
Journal:  Asian Pac J Cancer Prev       Date:  2021-11-01

Review 7.  Endometrial hyperplasia as a risk factor of endometrial cancer.

Authors:  Lisa K Nees; Sabine Heublein; Sahra Steinmacher; Ingolf Juhasz-Böss; Sara Brucker; Clemens B Tempfer; Markus Wallwiener
Journal:  Arch Gynecol Obstet       Date:  2022-01-10       Impact factor: 2.493

8.  Effect of Mirena Intrauterine Device on Endometrial Thickness, Quality of Life Score, and Curative Effect in Patients with Perimenopausal Abnormal Uterine Bleeding.

Authors:  Ying Yu; Zhi Zhou; Liping Wang; Jie Liu
Journal:  Comput Math Methods Med       Date:  2022-09-30       Impact factor: 2.809

9.  Progestogen-releasing intrauterine systems for heavy menstrual bleeding.

Authors:  Magdalena Bofill Rodriguez; Anne Lethaby; Vanessa Jordan
Journal:  Cochrane Database Syst Rev       Date:  2020-06-12

10.  Long-term outcome of endometrial ablation therapy with Cavaterm Thermal Balloon in patients with abnormal uterine bleeding

Authors:  Mojgan Karimi-Zarchi; Marzieh Fathi; Afsar Tabatabaie; Farimah Shamsi; Leila Allahqoli; Leila Zanbagh; Seyed Mohammad Amin Hashemipour; Liselotte Mettler
Journal:  J Turk Ger Gynecol Assoc       Date:  2019-09-09
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.